Cannabinoid Ligands Targeting TRP Channels C Muller, P Morales, P Reggio Frontiers in Molecular Neuroscience 111, Article 487, 2019 | 614 | 2019 |
Molecular targets of the phytocannabinoids: a complex picture P Morales, DP Hurst, PH Reggio Phytocannabinoids: Unraveling the complex Chemistry and Pharmacology of …, 2017 | 611 | 2017 |
An overview on medicinal chemistry of synthetic and natural derivatives of cannabidiol P Morales, PH Reggio, N Jagerovic Frontiers in pharmacology 8, 422, 2017 | 209 | 2017 |
An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors P Morales, PH Reggio Cannabis and cannabinoid research 2 (1), 265-273, 2017 | 205 | 2017 |
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders G Navarro, P Morales, C Rodríguez-Cueto, J Fernández-Ruiz, ... Frontiers in Neuroscience 10, 406, 2016 | 164 | 2016 |
Allosteric Modulators of the CB1 Cannabinoid Receptor: A Structural Update Review P Morales, P Goya, N Jagerovic, L Hernandez-Folgado Cannabis and Cannabinoid Research 1 (1), 22-30, 2016 | 111 | 2016 |
Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes G Navarro, I Reyes-Resina, R Rivas-Santisteban, VS de Medina, ... Biochemical pharmacology 157, 148-158, 2018 | 99 | 2018 |
Structural Insights into CB1 Receptor Biased Signaling R Al-Zoubi, P Morales, P Reggio International Journal of Molecular Sciences 20 (8), 1837, 2019 | 92 | 2019 |
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update P Morales, L Hernandez-Folgado, P Goya, N Jagerovic Expert opinion on therapeutic patents 26 (7), 843-856, 2016 | 91 | 2016 |
Emerging strategies targeting CB 2 cannabinoid receptor: Biased agonism and allosterism P Morales, P Goya, N Jagerovic Biochemical Pharmacology 157, 8-17, 2018 | 59 | 2018 |
Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12 P Morales, I Isawi, PH Reggio Drug metabolism reviews 50 (1), 74-93, 2018 | 58 | 2018 |
Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity P Morales, D Vara, M Gomez-Canas, MC Zúñiga, C Olea-Azar, P Goya, ... European Journal of Medicinal Chemistry 70, 111-119, 2013 | 58 | 2013 |
Therapeutic exploitation of GPR18: beyond the cannabinoids? Miniperspective P Morales, A Lago-Fernandez, DP Hurst, N Sotudeh, E Brailoiu, ... Journal of medicinal chemistry 63 (23), 14216-14227, 2020 | 55 | 2020 |
Advances towards the discovery of GPR55 ligands P Morales, N Jagerovic Current medicinal chemistry 23 (20), 2087-2100, 2016 | 53 | 2016 |
Chromenopyrazole, a versatile cannabinoid scaffold with in vivo activity in a model of multiple sclerosis P Morales, M Gómez-Cañas, G Navarro, DP Hurst, FJ Carrillo-Salinas, ... Journal of medicinal chemistry 59 (14), 6753-6771, 2016 | 47 | 2016 |
Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against Triple-Negative Breast Cancer P Morales, S Blasco-Benito, C Andradas, M Gómez-Cañas, JM Flores, ... Journal of medicinal chemistry 58 (5), 2256-2264, 2015 | 47 | 2015 |
Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding RE Ramírez-Orozco, R García-Ruiz, P Morales, CM Villalón, ... Current neuropharmacology 17 (10), 947-960, 2019 | 46 | 2019 |
Chromenopyrazoles: Non‐psychoactive and Selective CB1 Cannabinoid Agonists with Peripheral Antinociceptive Properties J Cumella, L Hernández‐Folgado, R Girón, E Sánchez, P Morales, ... ChemMedChem 7 (3), 452-463, 2012 | 43 | 2012 |
Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System A Lago-Fernandez, S Zarzo-Arias, N Jagerovic, P Morales International Journal of Molecular Sciences 22 (3), 1001, 2021 | 41 | 2021 |
A Molecular Modeling Approach to Identify Novel Inhibitors of the Major Facilitator Superfamily of Efflux Pump Transporters S Zarate, P Morales, K Świderek, V Bolanos-Garcia, A Bastida Antibiotics 8 (1), 25, 2019 | 41 | 2019 |